Success Stories: EB-1A Approved for a Senior Research Scientist in Texas in the Field of Pharmaceutical Science
Client’s Testimonial:
That's great news! Thank you very much for the tremendous help at each and every step of the process! I am very grateful for the immediate guidance you always provided. It was really a wonderful experience working with a great team of highly skilled professionals like you. Thank you again for everything!!
On January 26th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Senior Research Scientist in the Field of Pharmaceutical Science (Approval Notice)
Position at the Time of Case Filing: Senior Research Scientist
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Texas
Approval Notice Date: January 26th, 2015
Processing Time: 4 months, 4 days
For this case we worked with a pharmaceutical scientist from India with a specialized focus on the development and improvement of novel Ocular Drug Delivery methods and means. His highly prolific career thus far had produced 8 peer-reviewed scientific articles, 2 patents and 9 presentations at national and international conferences. He had been cited at least 131 times, primarily by independent researchers at prominent and leading institutions and organizations worldwide. This remarkable citation record clearly indicates the major significance of our client’s work. He had also reviewed at least 27 manuscripts for 6 or more distinctive, internationally-circulated journals. It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmaceutical Science, and that his continued research would substantially and prospectively benefit the United States. An independent recommender affirmed the significance of our client’s research: “[Client] has had a substantial impact on the field of pharmaceuticals, and especially ocular drug delivery, which sets him apart from his peers and places him among the top researchers in the field.” With the proof and documentation that we provided, his case was approved in 4 months and 4 days.